Shop By Brands
S
Shop By Brand
S
Home - ORTHOVISC®
ORTHOVISC® is administered via intra-articular injection into the synovial space of the knee. The procedure should only be performed by a licensed healthcare provider with experience in joint injections.
Key administration considerations include:
The number of injections required may vary depending on the selected product format.
Each formulation is optimized for different dosing preferences and anatomical requirements.
ORTHOVISC® is generally associated with mild and manageable side effects:
Most side effects resolve within 48–72 hours post-procedure.
Compared to other HA-based viscosupplements, ORTHOVISC® is distinguished by its high molecular weight, non-animal source, and adaptability for single or multiple injection formats. While some brands may use avian-derived hyaluronic acid, ORTHOVISC®’s synthetic origin reduces allergy risks and enhances patient tolerance.
Unlike corticosteroid injections, which only address inflammation, ORTHOVISC® offers mechanical joint protection through improved lubrication and long-term relief. For professionals looking to order ORTHOVISC as a reliable osteoarthritis treatment, it remains a leading choice in non-surgical joint therapy.
ORTHOVISC® is a high molecular weight hyaluronic acid (HA) viscosupplement used for the treatment of knee osteoarthritis. Derived from a non-animal source, its biocompatible formulation mimics the natural synovial fluid found in healthy joints.
Once injected intra-articularly, ORTHOVISC® helps restore the viscoelastic properties of the joint fluid, providing improved lubrication and shock absorption. This reduces friction between joint surfaces, thereby decreasing pain and improving mobility. The HA component also exhibits anti-inflammatory properties, further enhancing joint function over time.
ORTHOVISC® is primarily indicated for:
It is especially recommended for patients who have not responded adequately to conservative treatment methods such as physical therapy or oral NSAIDs.
ORTHOVISC® has been trusted globally for its clinical efficacy and safety profile. It is backed by a robust history of use in orthopedic care and stands out for several reasons:
Medical professionals prefer ORTHOVISC® for its consistent performance, ease of integration into orthopedic protocols, and long-standing reputation in joint health therapy.
The effects of ORTHOVISC® may be felt within the first few weeks after injection, with optimal relief occurring between 2 to 4 weeks post-treatment. Clinical studies show that a treatment course—typically one injection per week for three weeks—can provide pain relief lasting up to six months or more, depending on individual patient factors and activity levels.
ORTHOVISC® is generally well tolerated when administered by trained professionals. Its formulation is non-immunogenic and carries minimal risk of adverse events.
Common side effects are typically mild and transient, and may include:
Adherence to sterile technique and proper joint injection protocols significantly reduces the risk of complications.